Samantha Epistolio

13PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 30, 2025
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of KRAS Mutations.

Lucia Motta, Samantha Epistolio, Jana Pankovics

|Jul 29, 2025
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Lucia Motta, Francesca Molinari, Jana Pankovics

|Mar 27, 2025
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma.

Samantha Epistolio, Paolo Spina, Ismail Zaed

|Dec 17, 2024
Neo-RAS Wild Type or RAS Conversion in Metastatic Colorectal Cancer: A Comprehensive Narrative Review.

Guido Pesola, Samantha Epistolio, Marco Cefalì

|Apr 25, 2024
One-instrument, objective microsatellite instability analysis using high-resolution melt.

Kamilla Kolding Bendixen, Sofie Forsberg-Pho, Giulia Dazio

|Feb 09, 2024
Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis.

Samantha Epistolio, Giulia Dazio, Ismail Zaed

Pageof 3

Frequent Collaborators

4 joint publications

Milo Frattini

3 joint publications

Marco Cefalì

3 joint publications

Francesco Marchi

3 joint publications

Paolo Spina